Request Deal Involvement

Redmile Group led a $95m Series C funding round in Evox Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

FTI Consulting

pr advisors

FTI Consulting

or

Principals

EVOX THERAPEUTICS

target

EVOX THERAPEUTICS

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

OXFORD SCIENCES INNOVATION

bidder

OXFORD SCIENCES INNOVATION

GV (GOOGLE VENTURES)

bidder

GV (GOOGLE VENTURES)

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

bidder

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

REDMILE GROUP

bidder

REDMILE GROUP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Redmile Group led a $95m Series C funding round in Evox Therapeutics.